Long-term view |
|
| 1 |
|
|
|
|
|
|
|
|
|
|
|
Map patients |
| 2 |
| 2 | 1 | 1 | 1 |
|
|
|
| 1 | 1 |
|
Market profiling | 1 |
|
|
| 1 | 2 |
|
| 1 | 1 |
| 1 | 2 | 1 |
Market share? |
| 1 | 2 |
| 1 | 3 |
|
|
|
|
|
| 1 |
|
Medical plan |
|
|
|
|
|
|
| 1 |
|
|
|
|
|
|
Model-based meta-analysis |
|
|
|
|
|
|
|
|
|
|
| 2 |
|
|
More attractive partner |
|
|
|
| 1 |
|
|
|
|
| 2 | 1 |
| 1 |
MR dissemination | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
Patient finance |
|
|
|
| 1 |
|
|
|
| 1 |
|
|
|
|
PATIENT JOURNEY |
|
|
|
|
| 1 | 1 |
|
| 1 | 1 | 2 | 1 |
|
Patient profiling | 3 | 3 |
|
| 1 | 4 | 1 | 1 | 1 | 1 | 1 |
| 2 |
|
Patient societies | 1 | 2 | 1 |
| 1 |
|
|
| 1 |
|
|
|
|
|
Prepare the market | 1 | 1 | 1 |
|
| 1 |
|
|
|
|
|
| 1 |
|
Primary market research |
|
|
|
|
|
|
|
| 1 |
| 2 | 3 |
| 1 |
Prior relationship with decision-makers |
|
|
|
| 2 |
|
| 1 |
|
|
|
|
|
|
Product exclusivity | 1 | 1 | 2 |
| 1 |
|
|
| 1 |
| 2 |
| 1 |
|
Product fit in | 2 | 2 | 1 |
|
|
|
|
|
| 1 |
| 1 |
|
|
Product packaging |
| 1 |
|
|
|
|
| 1 |
| 1 |
|
|
|
|
Product perception |
|
|
|
| 1 |
|
| 1 |
|
|
|
|
|
|
Product prioritising |
| 1 |
| 1 |
|
|
|
|
|
|
| 2 | 2 |
|
Product profile | 1 |
| 2 |
|
|
|
|
|
|
|
|
|
|
|
Product uptake | 1 | 2 |
|
| 1 |
|
| 1 | 1 | 1 |
|
|
| 1 |
Provide education | 1 |
| 1 |
|
| 1 |
|
|
|
|
|
| 1 |
|
Provider Targeting | 2 | 1 | 2 |
|
|
| 1 |
| 1 |
|
|
| 2 |
|
Publicly available data | 1 |
|
|
| 1 | 2 |
|
| 2 | 1 | 1 | 1 | 1 |
|
Qualitative market research | 1 |
| 1 | 1 | 1 | 1 |
|
| 1 | 2 |
|
| 1 |
|
Quantitative market research | 1 |
| 1 |
| 1 |
|
|
| 1 | 1 |
|
|
|
|
Regulatory label | 1 | 1 |
|
|
|
|
|
| 2 | 2 |
|
| 1 |
|
RESPONSIVENESS |
|
|
|
|
| 3 | 1 |
| 1 |
| 1 | 1 |
|
|
Therapy switch (doctor) | 1 | 2 | 2 |
|
|
|
| 1 |
|
|
| 1 |
|
|
Therapy switch (patient) | 1 | 1 |
|
|
|
|
|
|
| 1 |
|
|
|
|
Therapy switch (payers) |
|
|
|
| 2 |
|
|
|
|
|
| 1 |
|
|
Treatment regimen | 2 | 3 | 2 |
| 2 | 1 | 2 |
|
| 2 |
| 1 | 2 |
|
Virtual development teams |
|
|
|
|
|
|
|
|
|
|
| 1 |
|
|
Wholesaler data |
|
|
|
|
|
|
|
| 1 |
|
|
|
|
|